Drug treats hepatitis C by targeting body's RNA

03/27/2013 | Science News

A new compound drug could be effective in treating hepatitis C by attacking RNA that allows the virus to gain traction in a patient's body. The drug, miravirsen, targets the body's microRNA-122, preventing viral replication, according to findings published in the New England Journal of Medicine. The treatment could potentially also treat other serious diseases, including cancer. "This is really a revolution in science and it's now beginning to be translated into advances that control disease," said Phillip Sharp, an MIT molecular biologist who won a 1993 Nobel Prize for work on RNA.

View Full Article in:

Science News

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL
San Francisco Unified is Accepting Applications for 2015-16!
San Francisco Unified school District
San Frnacisco, CA
San Francisco Unified is Accepting Applications for 2015-16!
San Francisco Unified School District
San Francisco, CA
Principal
Tapestry Public Charter School
Atlanta, GA
Assistant/Associate Professor, Department of Educational Leadership
Ball State University
Muncie, IN